These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 25942599

  • 1. Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.
    Wu Y, He S, Bai B, Zhang L, Xue L, Lin Z, Yang X, Zhu F, He P, Tang W, Zuo J.
    Cell Mol Immunol; 2016 May; 13(3):379-90. PubMed ID: 25942599
    [Abstract] [Full Text] [Related]

  • 2. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.
    Hou LF, He SJ, Li X, Yang Y, He PL, Zhou Y, Zhu FH, Yang YF, Li Y, Tang W, Zuo JP.
    Arthritis Rheum; 2011 Aug; 63(8):2445-55. PubMed ID: 21484768
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ, Li H, Jiang B, Nandakumar KS, Liu KF, Liu LX, Yu XC, Tan HJ, Zhou C.
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [Abstract] [Full Text] [Related]

  • 4. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice.
    Yan SX, Deng XM, Wang QT, Sun XJ, Wei W.
    Acta Pharmacol Sin; 2015 Nov; 36(11):1367-76. PubMed ID: 26456588
    [Abstract] [Full Text] [Related]

  • 5. Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL/lpr mice.
    Huang X, Xie Z, Liu F, Han C, Zhang D, Wang D, Bao X, Sun J, Wen C, Fan Y.
    Int Immunopharmacol; 2014 Sep; 22(1):266-72. PubMed ID: 25027631
    [Abstract] [Full Text] [Related]

  • 6. Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models.
    Sugahara K, Maeda Y, Shimano K, Murase M, Mochiduki S, Takemoto K, Kakimoto T, Utsumi H, Oshita K, Kataoka H.
    J Immunol Res; 2019 Sep; 2019():5821589. PubMed ID: 31930150
    [Abstract] [Full Text] [Related]

  • 7. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J, Fan H, Li F, Li X, Dong G, Gong W, Song Y, Liu F, Hua C, Tan R, Dou H, Hou Y.
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [Abstract] [Full Text] [Related]

  • 8. Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2.
    Lu LD, Stump KL, Wallace NH, Dobrzanski P, Serdikoff C, Gingrich DE, Dugan BJ, Angeles TS, Albom MS, Mason JL, Ator MA, Dorsey BD, Ruggeri BA, Seavey MM.
    J Immunol; 2011 Oct 01; 187(7):3840-53. PubMed ID: 21880982
    [Abstract] [Full Text] [Related]

  • 9. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 10. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A, Nakashima H, Masutani K, Miyake K, Shimizu S, Igawa T, Sugiyama N, Niiro H, Hirakata H, Harada M.
    Arthritis Rheum; 2005 Dec 15; 52(12):3987-96. PubMed ID: 16320345
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
    Hu L, Hu J, Chen L, Zhang Y, Wang Q, Yang X.
    Front Immunol; 2021 Dec 15; 12():584414. PubMed ID: 33717066
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
    Yang J, Li Q, Yang X, Li M.
    Mol Med; 2015 Apr 15; 21(1):364-70. PubMed ID: 25902303
    [Abstract] [Full Text] [Related]

  • 13. IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-Faslpr Mice.
    Wada Y, Gonzalez-Sanchez HM, Weinmann-Menke J, Iwata Y, Ajay AK, Meineck M, Kelley VR.
    J Am Soc Nephrol; 2019 Feb 15; 30(2):244-259. PubMed ID: 30622154
    [Abstract] [Full Text] [Related]

  • 14. Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.
    Moritoki M, Kadowaki T, Niki T, Nakano D, Soma G, Mori H, Kobara H, Masaki T, Kohno M, Hirashima M.
    PLoS One; 2013 Feb 15; 8(4):e60807. PubMed ID: 23585851
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice.
    Zhang X, Wang G, Bi Y, Jiang Z, Wang X.
    Int Immunopharmacol; 2022 Nov 15; 112():109133. PubMed ID: 36113317
    [Abstract] [Full Text] [Related]

  • 16. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
    Su B, Ye H, You X, Ni H, Chen X, Li L.
    Life Sci; 2018 Sep 01; 208():26-32. PubMed ID: 30146016
    [Abstract] [Full Text] [Related]

  • 17. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM, Stanley ER, Kelley VR.
    J Immunol; 2004 Oct 01; 173(7):4744-54. PubMed ID: 15383612
    [Abstract] [Full Text] [Related]

  • 18. A benzenediamine derivate FC-99 attenuates lupus nephritis in MRL/lpr mice via inhibiting myeloid dendritic cell-secreted BAFF.
    Ji J, Xu J, Li F, Li X, Gong W, Song Y, Dou H, Hou Y.
    Acta Biochim Biophys Sin (Shanghai); 2016 May 01; 48(5):411-9. PubMed ID: 27121231
    [Abstract] [Full Text] [Related]

  • 19. Pim-1 as a Therapeutic Target in Lupus Nephritis.
    Fu R, Xia Y, Li M, Mao R, Guo C, Zhou M, Tan H, Liu M, Wang S, Yang N, Zhao J.
    Arthritis Rheumatol; 2019 Aug 01; 71(8):1308-1318. PubMed ID: 30791224
    [Abstract] [Full Text] [Related]

  • 20. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L, Chen HP, Ma Q.
    Immunol Lett; 2014 Sep 01; 161(1):76-80. PubMed ID: 24837470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.